Increased expression of TGFβ and CTGF in hearts and in blood from patients with DCM, hypertrophic cardiomyopathy, and aortic stenosis has been confirmed but their relevance to ECM fibrosis remains unproven. This evidence concerns the gene TGFB1 and hypertrophic cardiomyopathy.